Scientific Sessions 2024  /  COVID-19 and Heart Failure  /  Comparative Proteomic Analysis of Myocarditis: COVID-19 mRNA Vaccination vs. Pre-Pandemic Viral Etiologies
Logo

American Heart Association

  127
  0

Final ID: MDP204

Comparative Proteomic Analysis of Myocarditis: COVID-19 mRNA Vaccination vs. Pre-Pandemic Viral Etiologies

Abstract Body (Do not enter title and authors here): Introduction: Myocarditis has been reported after mRNA-based COVID-19 vaccination, but the immune mechanisms remain unclear. This study aimed to identify the proteome-based immunopathogenesis of post-vaccination myocarditis compared to viral myocarditis in the pre-COVID-19 era.


Methods: Proteomic analysis of right ventricle (RV) biopsy specimens was performed in myocarditis patients (pre-pandemic viral myocarditis: n=3, post-vaccination myocarditis: n=3) and controls (normal endomyocardial biopsy specimens of heart transplant recipients, n=4) using mass spectrometry. Differentially expressed proteins were analyzed with CIBERSORTx, Gene Ontology (GO) analysis, and Ingenuity Pathway Analysis (IPA). To examine the relationship between the SARS-CoV-2 spike protein and post-vaccination myocarditis, immunohistochemistry (IHC), mass spectrometry analysis of spike protein, and activation-induced marker (AIM) assay in T cells from RV samples were conducted.


Results: In the proteomic analysis, 6,861 proteins were identified. Post-vaccination myocarditis showed increased extracellular matrix formation and cardiac fibrosis. Both pre-pandemic and post-vaccination myocarditis had elevated pro-inflammatory cytokine activities. However, post-vaccination myocarditis exhibited higher expression of interferon-alpha (IFNα) and pattern recognition receptor activation, including TLR3 and TLR7. Pre-pandemic myocarditis showed higher activation of the complement system, neutrophils, and NK cells, whereas post-vaccination myocarditis showed increased Th2 cell activation and classical macrophage activation. Spike protein and related T-cell activation were not detected.


Conclusion: The immune activation in myocarditis after COVID-19 mRNA vaccination may be triggered by the mRNA in the vaccine via an IFNα-driven immune response, leading to autoimmune-like features. Further studies are necessary to validate whether these proteins correlate with clinical characteristics.
  • Jang, Eunsom  ( St. Vincent’s Hospital, CMC , Suwon , Korea (the Republic of) )
  • Kim, Euisoon  ( Seoul St. Mary's Hospital, CMC , Seoul , Korea (the Republic of) )
  • Jung, Mi-hyang  ( Seoul St. Mary's Hospital, CMC , Seoul , Korea (the Republic of) )
  • Kim, In-cheol  ( Keimyung University , Daegu , Korea (the Republic of) )
  • Kim, Jong-seo  ( Seoul National University , Seoul , Korea (the Republic of) )
  • Youn, Jong-chan  ( Seoul St. Mary's Hospital, CMC , Seoul , Korea (the Republic of) )
    • Author Disclosures:
    Eunsom Jang: DO NOT have relevant financial relationships | Euisoon Kim: No Answer | Mi-Hyang Jung: DO NOT have relevant financial relationships | In-Cheol Kim: No Answer | Jong-Seo Kim: No Answer | Jong-Chan Youn: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

COVID-19 and Heart Failure

Saturday, 11/16/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
An innate immune component in hypertension-induced cardiac dysfunction
Christoph Mora, Katherine Deck, Yunmeng Liu, Lance Benson, Tonya Rafferty, & Shengyu Mu

Mora Christoph, Deck Katherine, Liu Yunmeng, Mu Shengyu, Benson Lance, Guo Yunping

An Integrative Strategy Combining Genetic, Proteomic, and Clinical Data Identifies Circulating WARS as a Candidate Target for Hypertension.

Chignon Arnaud, Lettre Guillaume

More abstracts from these authors:
Video Assisted Education to Improve Blood Pressure Control in Ischemic Heart Disease Patients with Hypertension (V-EDUCATE)
: A Randomized controlled trial

Kwon Minji, Kim In-cheol

Effect of Sacubitril/Valsartan in Patients with Concomitant Heart Failure with Reduced Ejection Fraction and End-Stage Renal Disease on Hemodialysis

Ahn Yuran, Jung Mi-hyang, Youn Jong-chan, Cho Dong-hyuk, Choi Jimi, Yoo Byung-su

4142506_File000000.jpg
4142506_File000000.jpg
You have to be authorized to contact abstract author. Please, Login
Not Available